Skip to main content

Remote Job Finders (RJF)

Roche’s late stage pipeline ‘so full,’ CEO Schinecker not feeling pressure to add on

Roche has 19 investigational medicines that could launch by 2030—and even if not all of them make it to market, the company is “well set-up for growth into the next decade,” CEO Thomas Schinecker said on the pharma’s Q2 earnings call.

Make or break: Commercial hires critical for success

With the stakes for successful launches high, and demand for commercial roles increasing, biopharmas must thoughtfully approach not only hiring but also retention. During a BioSpace webinar, experienced commercial leaders and a recruiter discussed the challenges employers face and how to tackle them.
Scroll to top